Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy

ClinicalTrials.gov ID: NCT03149003

Public ClinicalTrials.gov record NCT03149003. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 12:32 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multicenter, Adaptive Phase 3 Study of DSP-7888 Dosing Emulsion in Combination With Bevacizumab Versus Bevacizumab Alone in Patients With Recurrent or Progressive Glioblastoma Following Initial Therapy (WIZARD 201G)

Study identification

NCT ID
NCT03149003
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sumitomo Pharma America, Inc.
Industry
Enrollment
221 participants

Conditions and interventions

Conditions

Interventions

  • DSP-7888 Dosing Emulsion Drug
  • Bevacizumab Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Dec 7, 2017
Primary completion
Aug 29, 2021
Completion
Aug 29, 2021
Last update posted
Nov 14, 2023

2017 – 2021

United States locations

U.S. sites
37
U.S. states
21
U.S. cities
33
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
Center for Neurosciences Tucson Arizona 85718
Highlands Oncology Group Fayetteville Arkansas 72703
UCSD- Moores Cancer Center La Jolla California 92093
Kaiser Permanente Los Angeles Medical Center Los Angeles California 90027
Cedars Sinai Medical Center Los Angeles California 90048
Neuro-Oncology/ US Irvine Medical Center Orange California 92868
Sansum Clinic Santa Barbara California 93105
John Wayne Cancer Institute Santa Monica California 90404
Rocky Mountain Cancer Center Denver Colorado 80218
Piedmont brain tumor center Atlanta Georgia 30309
Rush University Medical Center Chicago Illinois 60612
University of Kentucky / Department of Internal Medicine / Markey Cancer Center Lexington Kentucky 40536
Norton Cancer Institute Louisville Kentucky 40202
Tufts Medical Center Boston Massachusetts 02111
Henry Ford Health System Detroit Michigan 48202
Abbott Northwestern Hospital Minneapolis Minnesota 55407
Hackensack University Medical Center Hackensack New Jersey 07601
Dent Neurosciences Research Center Amherst New York 14226
Weill Cornell Medicine New York New York 10021
Columbia University Medical Center/ Neurological Institute of NY New York New York 10032
University of Rochester Medical Center Rochester New York 14642
University Hospitals of Cleveland Cleveland Ohio 44106
Cleveland Clinic Taussig Cancer Center Cleveland Ohio 44195
University of Toledo Toledo Ohio 43606
Hospital of the University of Pennsylvania Philadelphia Pennsylvania 19104
University of Pittsburgh Medical Center (UPMC) Pittsburgh Pennsylvania 15232
Rhode Island Hospital Providence Rhode Island 02903
University of Tennessee Academic Medical Center Cancer Institute Knoxville Tennessee 37920
Texas Oncology Austin Midtown Austin Texas 78705
Baylor Scott and White Dallas Texas 75246
Houston Methodist Houston Texas 77030
Mischer Neuroscience Associates/Memorial Hermann Hospital Houston Texas 77030
Renovatio Clinical The Woodlands Texas 77380
Virginia Cancer Specialists, PC Fairfax Virginia 22031
Swedish Medical Center Seattle Washington 98122
University of Wisconsin Hospital Madison Wisconsin 53792

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03149003, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 14, 2023 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03149003 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →